Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program - Takeaways - MDSpire

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program

  • By

  • Kara Hlynsdottir

  • Sigurdur Olafsson

  • Ubaldo Benitez Hernandez

  • Mar Kristjansson

  • Magnus Gottfredsson

  • December 31, 2025

  • 0 min

Share

  • 1

    The TraP HepC program in Iceland, initiated in 2016, significantly reduced HIV/HCV coinfection rates by over 85% by 2020.

  • 2

    Direct-acting antivirals (DAAs) replaced interferon treatments, leading to a cure rate increase from 45% to 88% among coinfected individuals.

  • 3

    The study identified 84 active HCV infections, resulting in 81 treatment initiations and 66 successful cures.

  • 4

    Despite the decrease in coinfection rates, the reinfection rate among treated individuals was 9.35 per 100 person-years.

  • 5

    Iceland achieved WHO targets for HCV elimination, diagnosing over 90% of infections and treating at least 80% of eligible individuals.

Original Source(s)

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program

  • by Kara Hlynsdottir, Sigurdur Olafsson, Ubaldo Benitez Hernandez, Mar Kristjansson, Magnus Gottfredsson

  • December 31, 2025

Related Content

Is Point-of-Care Hepatitis C Virus Testing Too Expensive?

RNA testing carries substantial cost burden for hospitals, study finds

  • January 14, 2026

  • 2 min
Association of cancer-related cytokines and mitochondrial DNA alterations in hepatocellular carcinoma patients and HIV-positive individuals in Ghana

Routine vs. Risk-Based Vaccination

The CDC has dropped routine recommendations for six childhood vaccines, shifting decisions to parents and doctors despite decades of evidence showing the shots prevented millions of hospitalizations and tens of thousands of deaths.